BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 29532744)

  • 21. Complement activation predicts adverse pregnancy outcome in patients with systemic lupus erythematosus and/or antiphospholipid antibodies.
    Kim MY; Guerra MM; Kaplowitz E; Laskin CA; Petri M; Branch DW; Lockshin MD; Sammaritano LR; Merrill JT; Porter TF; Sawitzke A; Lynch AM; Buyon JP; Salmon JE
    Ann Rheum Dis; 2018 Apr; 77(4):549-555. PubMed ID: 29371202
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Positivity for anti-RNP antibody is a risk factor for adverse effects caused by trimethoprim-sulfamethoxazole, a prophylactic agent for P. jiroveci pneumonia, in patients with connective tissue diseases.
    Maezawa R; Kurasawa K; Arai S; Okada H; Owada T; Fukuda T
    Mod Rheumatol; 2013 Jan; 23(1):62-70. PubMed ID: 22466117
    [TBL] [Abstract][Full Text] [Related]  

  • 23. High-risk pregnancy and the rheumatologist.
    Soh MC; Nelson-Piercy C
    Rheumatology (Oxford); 2015 Apr; 54(4):572-87. PubMed ID: 25477056
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Outcome of pregnancies in lupus: experience at one center].
    De Bandt M; Palazzo E; Belmatoug N; M'Bappe P; Hayem G; Kahn MF; Meyer O
    Ann Med Interne (Paris); 2000 Mar; 151(2):87-92. PubMed ID: 10855360
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Fetal outcomes and associated factors of adverse outcomes of pregnancy in southern Chinese women with systemic lupus erythematosus.
    Zhan Z; Yang Y; Zhan Y; Chen D; Liang L; Yang X
    PLoS One; 2017; 12(4):e0176457. PubMed ID: 28441446
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pregnancy outcome of 126 anti-SSA/Ro-positive patients during the past 24 years--a retrospective cohort study.
    Luo Y; Zhang L; Fei Y; Li Y; Hao D; Liu Y; Zhao Y
    Clin Rheumatol; 2015 Oct; 34(10):1721-8. PubMed ID: 26384980
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pregnancy outcomes in women with childhood-onset and adult-onset systemic lupus erythematosus: a comparative study.
    Saavedra MÁ; Miranda-Hernández D; Sánchez A; Morales S; Cruz-Domínguez P; Medina G; Jara LJ
    Rheumatol Int; 2016 Oct; 36(10):1431-7. PubMed ID: 27387686
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Risk factors for adverse pregnancy outcomes in women with rheumatoid arthritis and follow-up of their offspring.
    Luo L; Li X; Yan R; Zhang H; Li C
    Clin Rheumatol; 2022 Oct; 41(10):3135-3141. PubMed ID: 35698010
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Neurologic disorders of pregnancy. Connective tissue disorders.
    Futrell N; Millikan C
    Neurol Clin; 1994 Aug; 12(3):527-39. PubMed ID: 7990789
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comorbid connective tissue diseases and autoantibodies in lymphangioleiomyomatosis: a retrospective cohort study.
    Futami S; Arai T; Hirose M; Sugimoto C; Ikegami N; Akira M; Kasai T; Kitaichi M; Hayashi S; Inoue Y
    Orphanet J Rare Dis; 2018 Oct; 13(1):182. PubMed ID: 30342527
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pregnancy outcome in systemic lupus erythematosus: Asia's largest single centre study.
    Aggarwal N; Raveendran A; Suri V; Chopra S; Sikka P; Sharma A
    Arch Gynecol Obstet; 2011 Aug; 284(2):281-5. PubMed ID: 20680313
    [TBL] [Abstract][Full Text] [Related]  

  • 32. "To be or not to be," ten years after: evidence for mixed connective tissue disease as a distinct entity.
    Cappelli S; Bellando Randone S; Martinović D; Tamas MM; Pasalić K; Allanore Y; Mosca M; Talarico R; Opris D; Kiss CG; Tausche AK; Cardarelli S; Riccieri V; Koneva O; Cuomo G; Becker MO; Sulli A; Guiducci S; Radić M; Bombardieri S; Aringer M; Cozzi F; Valesini G; Ananyeva L; Valentini G; Riemekasten G; Cutolo M; Ionescu R; Czirják L; Damjanov N; Rednic S; Matucci Cerinic M
    Semin Arthritis Rheum; 2012 Feb; 41(4):589-98. PubMed ID: 21959290
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Lupus anticoagulant is the main predictor of adverse pregnancy outcomes in aPL-positive patients: validation of PROMISSE study results.
    Yelnik CM; Laskin CA; Porter TF; Branch DW; Buyon JP; Guerra MM; Lockshin MD; Petri M; Merrill JT; Sammaritano LR; Kim MY; Salmon JE
    Lupus Sci Med; 2016; 3(1):e000131. PubMed ID: 26835148
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Obstetric and perinatal outcome in anti-Ro/SSA-positive pregnant women: a prospective cohort study.
    Martínez-Sánchez N; Pérez-Pinto S; Robles-Marhuenda Á; Arnalich-Fernández F; Martín Cameán M; Hueso Zalvide E; Bartha JL
    Immunol Res; 2017 Apr; 65(2):487-494. PubMed ID: 28138914
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prevalence and significance of previously undiagnosed rheumatic diseases in pregnancy.
    Spinillo A; Beneventi F; Ramoni V; Caporali R; Locatelli E; Simonetta M; Cavagnoli C; Alpini C; Albonico G; Prisco E; Montecucco C
    Ann Rheum Dis; 2012 Jun; 71(6):918-23. PubMed ID: 22294629
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Presence of antinucleosome autoantibodies in a restricted set of connective tissue diseases: antinucleosome antibodies of the IgG3 subclass are markers of renal pathogenicity in systemic lupus erythematosus.
    Amoura Z; Koutouzov S; Chabre H; Cacoub P; Amoura I; Musset L; Bach JF; Piette JC
    Arthritis Rheum; 2000 Jan; 43(1):76-84. PubMed ID: 10643702
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pregnancy outcomes in aquaporin-4-positive neuromyelitis optica spectrum disorder.
    Nour MM; Nakashima I; Coutinho E; Woodhall M; Sousa F; Revis J; Takai Y; George J; Kitley J; Santos ME; Nour JM; Cheng F; Kuroda H; Misu T; Martins-da-Silva A; DeLuca GC; Vincent A; Palace J; Waters P; Fujihara K; Leite MI
    Neurology; 2016 Jan; 86(1):79-87. PubMed ID: 26581304
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Maternal and foetal outcomes in pregnant systemic lupus erythematosus patients: an incident cohort from a stable referral population followed during 1990-2010.
    Jakobsen IM; Helmig RB; Stengaard-Pedersen K
    Scand J Rheumatol; 2015; 44(5):377-84. PubMed ID: 26087812
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Maternal and fetal outcome of lupus pregnancy: a prospective study of 29 pregnancies.
    Molad Y; Borkowski T; Monselise A; Ben-Haroush A; Sulkes J; Hod M; Feldberg D; Bar J
    Lupus; 2005; 14(2):145-51. PubMed ID: 15751819
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Obstetric outcomes and prognostic factors of lupus pregnancies.
    Madazli R; Yuksel MA; Oncul M; Imamoglu M; Yilmaz H
    Arch Gynecol Obstet; 2014 Jan; 289(1):49-53. PubMed ID: 23807699
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.